Poor Outcome and Prognosis of Hodgkin Lymphoma Treatment in Pakistan

被引：0
|
作者：
Fatima, A. [1 ]
Zaidi, S. [2 ]
机构：
[1] SKMC & RC, Pediat Oncol, Lahore, Pakistan
[2] Wecare Med Ctr, Lahore, Pakistan
来源：
PEDIATRIC BLOOD & CANCER | 2018年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO-233
引用
收藏
页码：S198 / S199
页数：2
相关论文
共 50 条
  • [41] High Serum Level of Soluble Programmed Death Ligand 1 is Associated With a Poor Prognosis in Hodgkin Lymphoma
    Guo, Xiaofang
    Wang, Juan
    Jin, Jietian
    Chen, Hao
    Zhen, Zijun
    Jiang, Wenqi
    Lin, Tongyu
    Huang, Huiqiang
    Xia, Zhongjun
    Sun, Xiaofei
    TRANSLATIONAL ONCOLOGY, 2018, 11 (03): : 779 - 785
  • [42] Increased expression of matrix metalloproteinases 2 and 9 as poor prognosis factor for Hodgkin's lymphoma patients
    Silva, Barbara de Oliveira
    Medeiros, Jonathan Wagner
    Albuquerque, Giwellington Silva
    Valderrama, Pavel Medina
    Barbosa, Athos Henrique de Quevedo
    de Souza, Juliana Maria
    Oliveira, Renata Santos
    Morais, Adriana Lins
    Neto, Jacinto da Costa Silva
    Muniz, Maria Tereza Cartaxo
    JORNAL DE PEDIATRIA, 2023, 99 (01) : 59 - 64
  • [43] T CELL REPLETE HAPLOIDENTICAL TRANSPLANTATION WITH POST-INFUSION CYCLOPHOSPHAMIDE IN POOR PROGNOSIS HODGKIN LYMPHOMA
    Castagna, L.
    Bramanti, S.
    Devillier, R.
    Crocchiolo, R.
    Furst, S.
    El Cheikh, J.
    Sarina, B.
    Granata, A.
    Faucher, C.
    Harbi, S.
    Morabito, L.
    Weiller, P. J.
    Chabannon, C.
    Mokart, J.
    Carlo-Stella, C.
    Santoro, A.
    Blaise, D.
    HAEMATOLOGICA, 2016, 101 : 48 - 48
  • [44] Three step high-dose chemotherapy in poor prognosis non-Hodgkin lymphoma.
    Ballestrero, A
    Clavio, M
    Ferrando, F
    Secondo, V
    Basta, P
    Gonella, R
    Garuti, A
    Miglino, M
    Pierri, I
    Canepa, L
    Beltrami, G
    Vallebella, E
    Ghio, R
    Gobbi, M
    Patrone, F
    BONE MARROW TRANSPLANTATION, 1998, 21 : S177 - S177
  • [45] Increased Expression of Matrix Metalloproteinases 2 and 9 as Poor Prognosis Factor for Hodgkin's Lymphoma Patients
    Silva, B. O.
    Valderrama, P. T. M.
    Medeiros, J. W.
    Albuquerque, G. S.
    Barbosa, A. H. Q.
    Oliveira, R. S.
    Souza, J. M.
    Morais, A. L.
    Neto, J. C. S.
    Muniz, M. T. C.
    KLINISCHE PADIATRIE, 2020, 232 (02): : 90 - 90
  • [46] T cell replete Haploidentical transplantation with post-infusion cyclophosphamide in poor prognosis Hodgkin lymphoma
    Castagna, L.
    Bramanti, S.
    Devillier, R.
    Crocchiolo, R.
    Furst, S.
    El Cheikh, J.
    Sarina, B.
    Granata, A.
    Faucher, C.
    Harbi, S.
    Morabito, L.
    Weiller, P. J.
    Chabannon, C.
    Carlo-Stella, C.
    Santoro, A.
    Blaise, D.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S159 - S160
  • [47] PROTEINURIA MAY REPRESENT SYSTEMIC INFLAMMATION LINKED WITH A POOR PROGNOSIS IN NON-HODGKIN LYMPHOMA PATIENTS
    Masaki, Hara
    Minoru, Ando
    Hirohiko, Nokiba
    Taku, Morito
    Ken, Tsuchiya
    Kosaku, Nitta
    NEPHROLOGY, 2014, 19 : 124 - 124
  • [48] Outcome of Lymphocyte Predominant Hodgkin Lymphoma
    Khalid, Arifa
    Zafar, Huma
    Wali, Rabia
    Riaz, Shazia
    Badar, Farhana
    BLOOD, 2014, 124 (21)
  • [49] Metabolic Tumor Volume Is an Independent Prognosis Factor Predicting patient's Outcome in Hodgkin Lymphoma
    Kanoun, Salim
    Rossi, Cedric
    Berriolo-Riedinger, Alina
    Humbert, Olivier
    Dygay-Cochet, Inna
    Chretien, Marie-Lorraine
    Legouge, Caroline
    Berthet, Louis
    Bastie, Jean-Noel
    Casasnovas, Rene-Olivier
    BLOOD, 2012, 120 (21)
  • [50] Demographics and Outcome in Paediatric Non Hodgkin Lymphoma: Single Centre Experience at the Children Hospital, Lahore, Pakistan
    Faizan, M.
    Anwar, S.
    Khan, S.
    Akram, S.
    Ahmad, A.
    Kashif, R.
    Ali, P. A. S.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S179 - S179
12345